doxylamine succinate 5 MG Chewable Tablet [Aldex AN]

RxNorm concept 1101441, branded drug (sbd). Prescribable name: ALDEX AN 5 MG Chewable Tablet.

RxCUI: 1101441
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1101441 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

doxylamine 3642

Other names

Aldex AN 5 MG Chewable Tablet

Related concepts

doxylamine succinate 5 MG (SCDC, consists of)
doxylamine succinate 5 MG [Aldex AN] (SBDC, consists of)
Chewable Tablet (DF, has dose form)
Aldex AN (BN, has ingredient)
doxylamine succinate 5 MG Chewable Tablet (SCD, tradename of)

Linked data

NDCs

65224054201

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1101441 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1101441 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1101441. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.